TY - GEN AU - Chen,Gege AU - Xu,Zhijian AU - Chang,Gaomei AU - Hou,Jun AU - Hu,Liangning AU - Zhang,Yiwen AU - Yu,Dandan AU - Li,Bo AU - Chang,Shuaikang AU - Xie,Yongsheng AU - Zhang,Yong AU - Wei,Rong AU - Wu,Huiqun AU - Xiao,Wenqin AU - Sun,Xi AU - Tao,Yi AU - Gao,Lu AU - Dai,Bojie AU - Shi,Jumei AU - Zhu,Weiliang TI - The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells SN - 1791-2431 PY - 2018///0326 KW - Antineoplastic Agents KW - pharmacology KW - Antineoplastic Combined Chemotherapy Protocols KW - Apoptosis KW - drug effects KW - Blueberry Plants KW - chemistry KW - Bortezomib KW - Caspases KW - metabolism KW - Cell Line, Tumor KW - Cell Proliferation KW - DNA Damage KW - Drug Resistance, Neoplasm KW - Drug Synergism KW - Histone Deacetylase Inhibitors KW - Humans KW - Hydroxamic Acids KW - Indoles KW - MAP Kinase Signaling System KW - Membrane Potential, Mitochondrial KW - Multiple Myeloma KW - drug therapy KW - Neoplasm Recurrence, Local KW - Panobinostat KW - S Phase Cell Cycle Checkpoints KW - Stilbenes KW - Vorinostat KW - p38 Mitogen-Activated Protein Kinases N1 - Publication Type: Journal Article UR - https://doi.org/10.3892/or.2017.5675 ER -